04 September 2020 : Original article
Transplantation of a Novel Recombinant Adeno-Associated Virus (pAAV-HE1B19K-TE1A) Demonstrates Higher Anti-Tumor Effects in Tumor Cells
Zhuo-Qing Li1BCDEF, Hong Shen2BCDE, Kun-Xian Shu3BCDF, Jian-Jun Li1BCDF, Yin Tang4BCD, Jing-Jing Su4BCF, Jun Yan1BCD, Jie Yang3BCF, Ze-Qing Wang1BCF, Yan Qiu4BC, Yong Yang1CF, Yang Liu4CF, Yong Zhou5BDEG*DOI: 10.12659/AOT.925013
Ann Transplant 2020; 25:e925013

Figure 3 E1B19K expression in cells detected using qPCR assay. (A – HepG2 cells, B – A549 cells, C – BGC-803 cells, D – HUVEC cells. 1 – cells without transfection, 2 – cells transfected with pAAV-IRES-ZsGreen, pHelper, and pAAV-RC, 3 – cells transfected with pAAV-HE1B19K-TE1A, pHelper, and pAAV-RC). *** p<0.0001 vs. pAAV-IRES-ZsGreen group in HepG2, A549, or BGC-803 cells.